Paradigms in oncology, old and new

C. Casey Cunningham, MD

From the Mary Crowley Medical Research Center and the Department of Oncology, Baylor University Medical Center, Dallas, Texas.

Corresponding author: C. Casey Cunningham, MD, 3535 Worth Street, Collins Building, Fifth Floor, Dallas, Texas 75246 (e-mail: Casey.Cunningham@USOncology.com).

In the past decades, medicine has shifted from primarily a study in physiology to one in cellular and molecular biology. The consequent new understanding of the most basic antecedents of disease has revolutionized many specialties, and none more so than oncology. With this new knowledge naturally come new approaches to treatment. Beginning with this issue of BUMC Proceedings, I will occasionally review some of these molecular approaches and outline a sampling of current trials. (BUMC Proceedings 2002;15:123-124)